I agree CR8,
The tech is exciting but the competition for Hep c cures is much greater than previously seen. New treatments (still not as good as a one off shot if it works) coming into market now against BLT still very early in clinical development, still preclin with Hep B and AMD, ideas about possible other uses. Like others I have made money here (in $1, out $2 -great!) but it looks like it is falling back to low $1 - and so it should with the dilution and so far to go to prove it's worth.
cheers all
I have noted my last couple of posts on HC have been downbeat - must be depressed!
DYOR, I know little to nothing about anything -still!
- Forums
- ASX - By Stock
- BLT
- thoughts
thoughts , page-13
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online